Literature DB >> 14013125

A controlled comparison of cycloserine plus ethionamide with cycloserine plus thiacetazone in patients with active pulmonary tuberculosis despite prolonged previous chemotherapy.

J H ANGEL, A L BHATIA, S DEVADATTA, W FOX, B JANARDHANAM, S RADHAKRISHNA, C V RAMAKRISHNAN, J B SELKON, H STOTT, S VELU.   

Abstract

Entities:  

Keywords:  CYCLOSERINE; DRUG RESISTANCE, MICROBIAL; ETHIONIAMIDE; THIOSEMICARBAZONES; TUBERCULOSIS, PULMONARY

Mesh：

Substances：

Year:  1963        PMID： 14013125     DOI： 10.1016/s0041-3879(63)80115-4

Source DB:  PubMed          Journal:  Tubercle        ISSN： 0041-3879


× No keyword cloud information.
  6 in total

Review 1.  Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosis.

Authors:  Kelly E Dooley; Carole D Mitnick; Mary Ann DeGroote; Ekwaro Obuku; Vera Belitsky; Carol D Hamilton; Mamodikoe Makhene; Sarita Shah; James C M Brust; Nadza Durakovic; Eric Nuermberger
Journal:  Clin Infect Dis       Date:  2012-05-21       Impact factor: 9.079

2.  A 5-year study of patients with pulmonary tuberculosis in a concurrent comparison of home and sanatorium treatment for one year with isoniazid plus PAS.

Authors:  J J Dawson; S Devadatta; W Fox; S Radhakrishna; C V Ramakrishnan; P R Somasundaram; H Stott; S P Tripathy; S Velu
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

3.  ACONCURRENT COMPARISON OF INTERMITTENT (TWICE-WEEKLY) ISONIAZID PLUS STREPTOMYCIN AND DAILY ISONIAZID PLUS PAS IN THE DOMICILIARY TREATMENT OF PULMONARY TUBERCULOSIS; TUBERCULOSIS CHEMOTHERAPY CENTRE, MADRAS.

Authors:  A LOTTE; F HATTON; S PERDRIZET; A ROUILLON
Journal:  Bull World Health Organ       Date:  1964       Impact factor: 9.408

4.  A 5-year study of patients with pulmonary tuberculosis treated at home in a controlled comparison of isoniazid plus PAS with 3 regimens of isoniazid alone.

Authors:  C Evans; S Devadatta; W Fox; P R Gangadharam; N K Menon; C V Ramakrishnan; S Sivasubramanian; P R Somasundaram; H Stott; S Velu
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

Review 5.  New Antituberculosis Drugs: From Clinical Trial to Programmatic Use.

Authors:  Gina Gualano; Susanna Capone; Alberto Matteelli; Fabrizio Palmieri
Journal:  Infect Dis Rep       Date:  2016-06-24

Review 6.  Treating tuberculosis with high doses of anti-TB drugs: mechanisms and outcomes.

Authors:  Yuhui Xu; Jianan Wu; Sha Liao; Zhaogang Sun
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-10-03       Impact factor: 3.944
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.